Cargando…
The mutational footprints of cancer therapies
Some cancer therapies damage DNA and cause mutations both in cancer and healthy cells of the patient. Therapy-induced mutations may underlie some of the long-term and late side effects of treatments, such as mental disabilities, organ toxicities and secondary neoplasms. Currently we ignore the mutat...
Autores principales: | Pich, Oriol, Muiños, Ferran, Paul Lolkema, Martijn, Steeghs, Neeltje, Gonzalez-Perez, Abel, Lopez-Bigas, Nuria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887544/ https://www.ncbi.nlm.nih.gov/pubmed/31740835 http://dx.doi.org/10.1038/s41588-019-0525-5 |
Ejemplares similares
-
The evolution of hematopoietic cells under cancer therapy
por: Pich, Oriol, et al.
Publicado: (2021) -
Copy number footprints of platinum-based anticancer therapies
por: Gonzalez, Santiago, et al.
Publicado: (2023) -
Reduced mutation rate in exons due to differential mismatch repair
por: Frigola, Joan, et al.
Publicado: (2017) -
OncodriveCLUSTL: a sequence-based clustering method to identify cancer drivers
por: Arnedo-Pac, Claudia, et al.
Publicado: (2019) -
OncodriveCLUSTL: a sequence-based clustering method to identify cancer drivers
por: Arnedo-Pac, Claudia, et al.
Publicado: (2019)